Neural Cell News

Neural Cell News is an online resource covering the latest research in neuroscience, neural stem cells, and neurological conditions.

Subscribe|Follow Us On

Multi-Omics Characterization of IDH-Mutant Astrocytoma-Derived Cell Lines Reveals NOTCH-Regulated Plastic Quiescent Astrocyte-Like State and Insights into Progression

August 5, 2026

[Acta Neuropathologica] Researchers established and extensively characterized four astrocytoma cell lines derived from IDH-mutant astrocytomas of different grades and analyzed them using multi-omics approaches.

Lipidomic Profiling Reveals Age-Dependent Changes in Plasma Membrane Lipids That Affect Neural Stem Cell Aging

August 5, 2026

[Science Advances] Using lipidomic profiling by mass spectrometry, investigators identified age-related changes in complex lipids in quiescent neural stem cells in vitro and in vivo.

Glial Heterogeneity Shapes Region-Specific Angiogenesis and Neurovascular Integrity in the CNS

August 5, 2026

[Science Advances] Through analyzing glial cell profiles combined with genetic ablation approaches, scientists uncovered distinct pro-angiogenic programs in astrocytic and oligodendroglial lineages that differentially regulate gray and white matter vascularization.

ROS-Driven Mitophagy Arrest Mediates the Anti-Glioblastoma Activity of Molephantin

August 5, 2026

[Autophagy] The authors established that targeting late-stage mitophagy flux via reactive oxygen species (ROS) modulation is a valuable paradigm for the discovery and development of therapeutic agents against glioblastoma.

CellCover Defines Marker Gene Panels Capturing Developmental Progression in Neocortical Neural Stem Cell Identity

August 5, 2026

[Elife] Using blood and brain data, investigators showed that their method, CellCover, reduces gene redundancy and captures cell-class-specific signals distinct from those found by differential expression.

PGC-1α Mediates ER Stress-Driven Apoptotic Signaling during Gemfibrozil Treatment in Glioblastoma

August 5, 2026

[European Journal of Pharmacology] Scientists investigated the complex interplay among key homeostatic pathways, specifically autophagy, endoplasmic reticulum stress, and calcium signalling, following Gemfibrozil exposure in the context of glioblastoma progression and treatment resistance.

Glioblastoma: Overcoming Fundamental Biological and Delivery Barriers to Therapy

August 5, 2026

[Science Translational Medicine] Investigators review emerging strategies to overcome the biological and drug delivery barriers limiting glioblastoma treatment, highlighting advances in precision medicine, immunotherapy, and targeted delivery technologies.

Targeting TDP-43 in Sporadic Amyotrophic Lateral Sclerosis

August 5, 2026

[Journal of Neurology] The authors examine key biological mechanisms underlying TDP-43 pathology, emerging therapeutic strategies, and evolving approaches to clinical trial design and biomarker development.

URI Receives $1.5 Million Grant to Study Disease Prevalent in Elderly Population and Those with Alzheimer’s Disease

August 5, 2026

[] William Van Nostrand, co-executive director of the University of Rhode Island's (URI) Ryan Institute for Neuroscience, has received a $1.5 million grant to study cerebral amyloid angiopathy, a condition common in older adults and people with Alzheimer's disease.

Atypical Chemokine Receptor 3 Regulates Synaptic Removal in Disease Astrocytes

July 22, 2026

[Molecular Neurodegeneration] Investigators demonstrated that the Atypical chemokine receptor 3 is a major player of astrocyte-mediated synapse engulfment.

AQP4-Dependent Enhancement of Glymphatic Function Attenuates Tau Pathology and Neurodegeneration in PS19 Mice

July 22, 2026

[Molecular Neurodegeneration] Researchers showed that enhancing AQP4-dependent glymphatic function reduces tau pathology and neurodegeneration, identifying glymphatic modulation as a promising therapeutic strategy for tau-related brain disorders.

MARCKS As a Mediator and Target for Pathological Tunneling Nanotubes Between Patient-Derived Glioblastoma Cells and Astrocytes

July 22, 2026

[Cell Death & Disease] The authors demonstrated a role for the Myristoylated Alanine Rich C-Kinase Substrate (MARCKS) effector domain and PKC activation in the formation and functionality of tunneling nanotubes between PTEN-null glioblastoma brain tumor–initiating cells and normal human astrocytes.

Neural Cell News helps scientists keep pace with the latest research, reviews, and industry developments in neuroscience. Specific research topics include neural development and neuroregeneration, neural signaling related to cellular responses and behavior, and synaptic plasticity. Research into the diagnosis, progression, cellular characteristics, and treatment of brain diseases such as Parkinson’s, Multiple Sclerosis, Alzheimer’s, Amyotrophic Lateral Sclerosis and various brain cancers, as well as brain damage resulting from infection, trauma, stroke, seizures, and tumors, is also covered.